NeoGenomics Statistics Share Statistics NeoGenomics has 25.47M
shares outstanding. The number of shares has increased by -79.92%
in one year.
Shares Outstanding 25.47M Shares Change (YoY) -79.92% Shares Change (QoQ) -79.96% Owned by Institutions (%) 99.08% Shares Floating 25.01M Failed to Deliver (FTD) Shares 208,987 FTD / Avg. Volume 8.41%
Short Selling Information The latest short interest is 5.37M, so 4.16% of the outstanding
shares have been sold short.
Short Interest 5.37M Short % of Shares Out 4.16% Short % of Float 5.73% Short Ratio (days to cover) 2.27
Valuation Ratios The PE ratio is -5.3 and the forward
PE ratio is 44.78.
NeoGenomics's PEG ratio is
0.46.
PE Ratio -5.3 Forward PE 44.78 PS Ratio 0.63 Forward PS 0.3 PB Ratio 0.46 P/FCF Ratio -12.26 PEG Ratio 0.46
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for NeoGenomics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.98,
with a Debt / Equity ratio of 0.67.
Current Ratio 1.98 Quick Ratio 1.89 Debt / Equity 0.67 Debt / EBITDA -400.62 Debt / FCF -17.78 Interest Coverage -13.92
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $300.26K Profits Per Employee $-35.78K Employee Count 2,200 Asset Turnover 0.4 Inventory Turnover 13.85
Taxes Income Tax -1.95M Effective Tax Rate 2.42%
Stock Price Statistics The stock price has increased by -50.25% in the
last 52 weeks. The beta is 1.61, so NeoGenomics's
price volatility has been higher than the market average.
Beta 1.61 52-Week Price Change -50.25% 50-Day Moving Average 6.67 200-Day Moving Average 10.44 Relative Strength Index (RSI) 63.99 Average Volume (20 Days) 2,485,901
Income Statement In the last 12 months, NeoGenomics had revenue of 660.57M
and earned -78.73M
in profits. Earnings per share was -3.1.
Revenue 660.57M Gross Profit 290.1M Operating Income -92.11M Net Income -78.73M EBITDA -1.51M EBIT -74.06M Earnings Per Share (EPS) -3.1
Full Income Statement Balance Sheet The company has 367.01M in cash and 605.33M in
debt, giving a net cash position of -238.32M.
Cash & Cash Equivalents 367.01M Total Debt 605.33M Net Cash -238.32M Retained Earnings -325.78M Total Assets 1.39B Working Capital 292.43M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 7.02M
and capital expenditures -41.06M, giving a free cash flow of -34.04M.
Operating Cash Flow 7.02M Capital Expenditures -41.06M Free Cash Flow -34.04M FCF Per Share -1.34
Full Cash Flow Statement Margins Gross margin is 43.92%, with operating and profit margins of -13.94% and -11.92%.
Gross Margin 43.92% Operating Margin -13.94% Pretax Margin -12.21% Profit Margin -11.92% EBITDA Margin -0.23% EBIT Margin -13.94% FCF Margin -5.15%
Dividends & Yields NEO does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for NEO is $11,
which is 37.8% higher than the current price. The consensus rating is "Buy".
Price Target $11 Price Target Difference 37.8% Analyst Consensus Buy Analyst Count 9
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Apr 16, 2003. It was a
backward
split with a ratio of 1:100.
Last Split Date Apr 16, 2003 Split Type backward Split Ratio 1:100
Scores Altman Z-Score 0.24 Piotroski F-Score 4
